公開日期 | 標題 | 作者 | 來源出版物 | scopus | WOS | 全文 |
---|---|---|---|---|---|---|
2006 | Differential expression of molecular markers in arsenic- and non-arsenic-related urothelial cancer | Hour T.-C.; YEONG-SHIAU PU ; CHIA-CHI LIN ; SHI-WEI HUANG ; Chen J.; Chiu A.W.; Chen C.-J.; CHAO-YUAN HUANG | Anticancer Research | 10 | 8 | |
2009 | Down regulation of ABCD1 in human renal cell carcinoma | Hour T.-C.; Kuo Y.-Z.; Liu G.-Y.; Kang W.-Y.; CHAO-YUAN HUANG ; YU-CHIEH TSAI ; Wu W.-J.; Huang S.-P.; YEONG-SHIAU PU | International Journal of Biological Markers | 9 | 9 | |
2008 | Down-regulated expression of RhoA in human conventional renal cell carcinoma | YEONG-SHIAU PU ; Wang C.-W.; Liu G.-Y.; Kuo Y.-Z.; CHAO YUAN HUANG ; Kang W.-Y.; CHIA-TUNG SHUN ; CHIA-CHI LIN ; Wu W.-J.; Hour T.-C. | Anticancer Research | 5 | 5 | |
2015 | EGFR mediates docetaxel resistance in human castration-resistant prostate cancer through the Akt-dependent expression of ABCB1 (MDR1) | Hour T.-C.; Chung S.-D.; Kang W.-Y.; Lin Y.-C.; Chuang S.-J.; Huang A.-M.; Wu W.-J.; Huang S.-P.; CHAO-YUAN HUANG ; YEONG-SHIAU PU | Archives of Toxicology | 44 | 38 | |
2006 | Epidermal growth factor receptor inhibitor (PD168393) potentiates cytotoxic effects of paclitaxel against androgen-independent prostate cancer cells | YEONG-SHIAU PU ; Hsieh M.-W.; Wang C.-W.; Liu G.-Y.; CHAO-YUAN HUANG ; CHIA-CHI LIN ; Guan J.-Y.; Lin S.-R.; Hour T.-C. | Biochemical Pharmacology | 38 | 35 | |
2012 | Genetic polymorphisms in oestrogen receptor-binding sites affect clinical outcomes in patients with prostate cancer receiving androgen-deprivation therapy | Huang C.-N.; Huang S.-P.; Pao J.-B.; Hour T.-C.; Chang T.-Y.; Lan Y.-H.; Lu T.-L.; Lee H.-Z.; Juang S.-H.; Wu P.-P.; CHAO-YUAN HUANG ; Hsieh C.-J.; Bao B.-Y. | Journal of Internal Medicine | 32 | 31 | |
2012 | Genetic variants in CASP3, BMP5, and IRS2 genes may influence survival in prostate cancer patients receiving androgen-deprivation therapy | Huang S.-P.; Bao B.-Y.; Hour T.-C.; CHAO-YUAN HUANG ; Yu C.-C.; Liu C.-C.; Lee Y.-C.; Huang C.-N.; Pao J.-B.; Huang C.-H. | PLoS ONE | 16 | 29 | |
2004 | Interleukin-6 is responsible for drug resistance and anti-apoptotic effects in prostatic cancer cells | YEONG-SHIAU PU ; Hour T.-C.; Chuang S.-E.; ANN-LII CHENG ; Lai M.-K.; Kuo M.-L. | Prostate | 70 | 71 | |
2014 | Involvement of p38 mitogen-activated protein kinase in acquired gemcitabine-resistant human urothelial carcinoma sublines | Kao Y.-T.; Hsu W.-C.; Hu H.-T.; Hsu S.-H.; Lin C.-S.; Chiu C.-C.; Lu C.-Y.; Hour T.-C.; YEONG-SHIAU PU ; Huang A.-M. | Kaohsiung Journal of Medical Sciences | 11 | 10 | |
2010 | Ling-zhi polysaccharides potentiate cytotoxic effects of anticancer drugs against drug-resistant urothelial carcinoma cells | CHAO-YUAN HUANG ; Chen J.Y.-F.; Wu J.-E.; YEONG-SHIAU PU ; Liu G.-Y.; Pan M.-H.; Huang Y.-T.; Huang A.-M.; Hwang C.-C.; Chung S.-J.; Hour T.-C. | Journal of Agricultural and Food Chemistry | 44 | 38 | |
2017 | MiR-193b Mediates CEBPD-Induced Cisplatin Sensitization Through Targeting ETS1 and Cyclin D1 in Human Urothelial Carcinoma Cells | Lin S.-R.; Yeh H.-C.; Wang W.-J.; Ke H.-L.; Lin H.-H.; Hsu W.-C.; Chao S.-Y.; Hour T.-C.; Wu W.-J.; YEONG-SHIAU PU ; Huang A.-M. | Journal of Cellular Biochemistry | 29 | 29 | |
2013 | Molecular Markers in Sex Hormone Pathway Genes Associated with the Efficacy of Androgen-Deprivation Therapy for Prostate Cancer | Yu C.-C.; Huang S.-P.; Lee Y.-C.; CHAO-YUAN HUANG ; Liu C.-C.; Hour T.-C.; Huang C.-N.; You B.-J.; Chang T.-Y.; Huang C.-H.; Bao B.-Y. | PLoS ONE | 22 | 151 | |
2009 | Phloroglucinols Inhibit Chemical Mediators and Xanthine Oxidase, and Protect Cisplatin-Induced Cell Death by Reducing Reactive Oxygen Species in Normal Human Urothelial and Bladder Cancer Cells | Lin K.-W.; Huang A.-M.; Tu H.-Y.; Weng J.-R.U.; Hour T.-C.; Wei B.-L.; Yang S.-C.; Wang J.-P.; YEONG-SHIAU PU ; Lin C.-N. | Journal of Agricultural and Food Chemistry | 11 | 11 | |
2017 | Preliminary evidence of polymorphisms of cell cycle regulatory genes and their roles in urinary tract urothelial cancer susceptibility and prognosis in a Taiwan population | Lin Y.-C.; Hour T.-C.; YU-CHIEH TSAI ; Huang S.-P.; Wu W.-J.; CHUNG-HSIN CHEN ; YEONG-SHIAU PU ; Chung S.-D.; CHAO-YUAN HUANG | Urologic Oncology: Seminars and Original Investigations | 11 | 10 | |
2005 | Resistance to paclitaxel is proportional to cellular total antioxidant capacity | Ramanathan B.; Jan K.-Y.; Chen C.-H.; Hour T.-C.; HONG-JENG YU ; YEONG-SHIAU PU | Cancer Research | 244 | 231 | |
2010 | Synthesis and biological evaluation of 2′,5′-dimethoxychalcone derivatives as microtubule-targeted anticancer agents | Tu H.-Y.; Huang A.-M.; Hour T.-C.; Yang S.-C.; YEONG-SHIAU PU ; Lin C.-N. | Bioorganic and Medicinal Chemistry | 29 | 28 | |
2010 | Terpenoids induce cell cycle arrest and apoptosis from the stems of Celastrus kusanoi associated with reactive oxygen species | Chen H.-L.; Lin K.-W.; Huang A.-M.; Tu H.-Y.; Wei B.-L.; Hour T.-C.; Yen M.-H.; YEONG-SHIAU PU ; Lin C.-N. | Journal of Agricultural and Food Chemistry | 25 | 20 | |
2010 | Transcriptional up-regulation of SOD1 by CEBPD: A potential target for cisplatin resistant human urothelial carcinoma cells | Hour T.-C.; Lai Y.-L.; Kuan C.-I.; Chou C.-K.; Wang J.-M.; Tu H.-Y.; Hu H.-T.; Lin C.-S.; Wu W.-J.; YEONG-SHIAU PU ; Sterneck E.; Huang A.-M. | Biochemical Pharmacology | 55 | 56 | |
2011 | UBE2M-mediated p27Kip1 degradation in gemcitabine cytotoxicity | Huang A.-M.; Kao Y.-T.; Toh S.; Lin P.-Y.; Chou C.-H.; Hu H.-T.; Lu C.-Y.; Liou J.-Y.; Chao S.-Y.; Hour T.-C.; YEONG-SHIAU PU | Biochemical Pharmacology | 14 | 12 | |
2009 | Ursolic acid derivatives induce cell cycle arrest and apoptosis in NTUB1 cells associated with reactive oxygen species | Tu H.-Y.; Huang A.-M.; Wei B.-L.; Gan K.-H.; Hour T.-C.; Yang S.-C.; YEONG-SHIAU PU ; Lin C.-N. | Bioorganic and Medicinal Chemistry | 83 | 74 |